Eclevar MedTech partners with ASAHI INTECC on cardiovascular evidence.

Paris, 21 October 2024 — Eclevar MedTech, a leading European contract research organization (CRO) specializing in medical devices, is proud to announce its collaboration with ASAHI INTECC, a Japanese manufacturer of medical devices, to provide consulting expertise in clinical evaluation and post-market clinical follow-up (PMCF) strategies in the interventional cardiovascular area. This partnership marks a crucial step for both companies, aiming to enhance innovation and bring ASAHI INTECC’s products into compliance with the European requirements of the MDR 2017/745.

About ASAHI INTECC

ASAHI INTECC is a global leader in the development and manufacturing of medical devices, primarily focused on the cardiovascular field. The company specializes in high-quality guidewires, microcatheters and other interventional products used in minimally invasive procedures, and is renowned for its proprietary technologies in wire drawing, forming and braiding.

How Eclevar supports the program

Eclevar brings a tech-enabled service tailored to the medtech industry, an international team of experts, and a clinical trial platform that speeds site feasibility and patient identification, alongside a state-of-the-art eCOA/ePRO platform, to support clinical evaluation and PMCF for a Class III vascular catheter device.